Category: Corona Virus

For posterity’s sake I want to be sure to get this article entered into my blog:

https://fee.org/articles/john-ioannidis-warned-covid-19-could-be-a-once-in-a-century-data-fiasco-he-was-right/

[…]

COVID-19 has been far from the deadliest virus in modern history, but it has been the most divisive. The public, politicians, policy experts, and public health officials have disagreed on how deadly it is and how best to contain it.

But the one thing everyone seems to agree on is the numbers we have—fatalities and cases—are way wrong. A new CDC report estimates COVID-19 rates about 10 times higher than reported. Ioannidis put the figure even higher, estimating weeks ago that as many 300 million people had already been infected globally.

Deaths are more complicated.

The New York Times says COVID-19 deaths have been massively undercounted. Dr. Ashish Jha, speaking to Lawrence O’Donnell on MSNBC, agreed, saying most experts agreed there is a “substantial undercount.”

Others, including nearly one-third of Americans according to a recent survey, believe that the COVID-19 death toll is inflated. This includes physicians who say medical professionals are being pressured by hospital administrators to add coronavirus to death sheets.

Writing at the American Mind, Angelo Codevilla recently argued if the CDC had used the same criterion for the SARS virus as COVID-19—primarily “severe acute respiratory distress syndrome”—total COVID fatalities in the US would have been 16,000 through June.

Nobody knows the true count, of course. But the one thing left and right seem to agree on is the data we have are junk. And yet the lesson we keep hearing is “trust the experts.”

“Follow the science. Listen to the experts. Do what they tell you,”

PLEASE READ DETAILS & HOW YOU CAN HELP HERE.

https://www.coreysdigs.com/health-science/vax-zealots-try-to-put-their-message-in-a-bottle/

https://c19study.com/

Each study listed above is hyperlinked for further investigation.

In Vitro, Meta, Theory, Safety, Review, News, and Retracted items are not included in the percentages and study count. There is a total of 116 items. Positive/negative effects vary in degree and certainty, please read the papers or descriptions thereof for more details. Every study has some limitations when considered in isolation (for example confounding factors; sub-optimal treatment regimens; dosing regimens that may be too low, too high, or insufficiently account for the long half-life of HCQ; large treatment delays; small sample sizes; lack of focus on severity; reliance on Internet surveys; and patient characteristics very different from the most at-risk population).

Rapid, daily, inexpensive COVID-19 tests can allow us to safely reopen schools and the economy.

Existing technology using paper strips allows for rapid, inexpensive COVID-19 testing of asymptomatic individuals. Research shows that if done properly, these testing protocols could drive down infections close to zero.

Millions of these tests can easily be manufactured and distributed.

At as low as $1 per test, you can take a test every day. Tests could be administered at the entrance to schools and offices, and some could be taken at home.

Rapid tests of this type are currently not approved for this type of use, since they do not meet strict sensitivity requirements.

PLEASE READ DETAILS & HOW YOU CAN HELP HERE.

Hydroxychloroquine report from five time Emmy Award winner & recipient of the Edward R Murrow award for investigative journalism, Sharyl Attkisson. Follow the $. It’s from May 18th, but even more pertinent today.

By HARVEY A. RISCH, MD, PHD
PROFESSOR OF EPIDEMIOLOGY; YALE SCHOOL OF PUBLIC HEALTH

This is an opinion article written by a Yale epidemiology Professor who has authored over 300 peer-reviewed publications.

https://www.newsweek.com/key-defeating-covid-19-already-exists-we-need-start-using-it-opinion-1519535

Risch paper submitted to the American Journal of epidemiology: https://academic.oup.com/aje/article/doi/10.1093/aje/kwaa152/5873640

It concludes:

Before reading this announcement please refer to previous post MEDCRAM UPDATE 98 “Could This Test Resolve the Back-To-Work/School Issue?”
.

This Week in Virology (Episode 640)

https://www.pharmaceutical-technology.com/news/study-fenofibrate-covid-19/
Notice this drug is currently in use to treat high cholesterol.

According to the research, the virus leads to deposits of lipids in the lungs. Nahmias partnered with Mount Sinai Medical Center researcher Dr Benjamin tenOever to gain better insights into SARS-CoV-2 mechanism of attack on the human body.

The researchers observed that the virus changes lipid metabolism in human lungs. They believe that halting this process could help prevent the onset of problems that increase the severity of the disease.

While SARS-CoV-2 hinders the ability of the body to break down fat, fenofibrate starts this process by binding and activating the DNA site that is blocked by the virus.